Man Survives Rare Cancer Thanks to New ‘Targeted’ Therapy
September 16, 2014
(ABC News) – Traditional cancer drugs are indiscriminant, attacking not just cancer cells but every living cell in the body. Molecular targeting agents like the one Lagno received – which are no longer experimental and are being used with increasing frequency – are designed to target specific cancer mutations, explained Washington University in St. Louis cancer researcher, Elaine Mardis. “Many cancers revolve around novel proteins that are highly active and constantly stimulated so that the growth of cancer is stimulated,” Mardis said. “These new targeted drugs seek out these novel proteins and shut them down.”